Skip to content
AwardedUnited KingdomGoods

Human Papillomavirus (2025)

Published
Published 16 October 2025
Deadline
Closed 4 December 2024

Overview

Contract for the supply of human papillomavirus vaccine to be used as part of the national immunisation programme. Deliveries will be required for a four year period from December 2025 Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

Key details

Country
United Kingdom
Status
Awarded
Category
Goods
Procedure
Limited
SME suitable
No
Published
16 October 2025
Deadline
Closed
Classification (CPV)
Vaccines

Award outcome

Awarded value
£2
Award date
9 October 2025
Contract period
1 December 2025 → 30 November 2029
Winner
  • Merck Sharpe & Dohme (UK) Limited

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    16 October 2025

  2. Contract Award Notice

    16 October 2025

Contracting authority

  • UK Health Security Agency

    Buyer

    London, United Kingdom

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Human Papillomavirus (2025) — won by Merck Sharpe & Dohme (UK) Limited — Skim